News & insights
News from Claris.
Progress across the portfolio.
Firm news, portfolio developments, partnerships and perspectives from across the Claris Ventures platform.
Archive
News and milestones.
Announcements from Claris Ventures and the companies we support.
2025
2024
Claris Ventures Claris Ventures and Exor Ventures Team Up for the Development of Innovative Drugs in Italy Turin, May 14, 2024 – Claris Ventures and Exor Ventures are joining forces in a new initiative aimed at developing innovative drugs in collaboration with Italian universities and research centers. Read more ↗ Claris Ventures Claris Ventures and Evotec Forge Powerful Partnership to Fast-Track Portfolio Programs Into Clinical Advancement Hamburg, Germany, and Turin, Italy, 06 March 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and biotech venture capital firm Claris Ventures (“Claris”) today announced an acceleration… Read more ↗
2023
Newly launched TCR company ALKemist Bio announces a €6.9M Investment Round to develop first-in-class TCR Cell Therapy for ALK-Positive Tumors Turin, Italy — December 21st 2023 — ALKemist Bio emerges from the research conducted by Roberto Chiarle, Professor of pathology at the University of Turin and Director of the haemolymphopathology Department of the European… Read more ↗ 
Claris Ventures appoints pharmaceutical industry veteran Michael Hodges as a Partner February 27 th , 2023 – Claris Ventures, a biotech venture capital fund based in Turin (Italy), is appointing Dr. Michael R. Hodges, MD as a Partner to the Investment team. The firm had a final closing of its first fund at €85m, in… Read more ↗ 
Sibylla Biotech raises €23 Million Series A VERONA, Italy–( BUSINESS WIRE )– Sibylla Biotech today announced the successful close of its €23 million Series A financing round to fund the further development of its Pharmacological Protein Inactivation by Folding Intermediate… Read more ↗ 2022
IAMA Therapeutics raises €8 million Series A IAMA THERAPEUTICS RACCOGLIE 8 MILIONI DI EURO PER LO SVILUPPO DI UN NUOVO CANDIDATO FARMACO PER LE DISFUNZIONI DEL NEUROSVILUPPO Read more ↗ 
Heqet Therapeutics raises €8 million March 23 rd , 2022 – Heqet Therapeutics, a King’s College London biotech spin-out active in the field of regenerative medicine, today announces the closing of a €8m Series A financing round, led by Claris Ventures and 2Invest. Read more ↗ 
Kither Biotech Raises €18.5 Million Series B Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Officer Read more ↗ 2021
Claris Biotech I Final Closing Fund oversubscription, one year after its launch by the Turin based SGR Read more ↗ 
NeoPhore Announces $21m Financing to Advance DNA Mismatch Repair Pipeline 09 March 2021, Cambridge, UK – NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces the close of a £15.2m (US $21m) Series B round. The syndicate was led by Claris Ventures and included 2Invest, 3B… Read more ↗ 2020
Claris Ventures launches a fund dedicated to Italian biotech Primo closing a quota €30m per Claris Biotech I, fondo biotech promosso da Claris Ventures SGR Read more ↗ 
Claris Ventures sulla rivista Prisma di Aprile La rivista Prisma nel mese di aprile dedica un articolo a Claris Ventures. Read more ↗ 
COVID-19: Claris Ventures publishes its report on vaccines and drugs in development Claris Ventures pubblished a Vaccines & Treatments Development Snapshot for Covid-19 in order to map all possible treatments. Report is update to 2020.03.23. Click the button below to see the report. Read more ↗ 
Business Insider: Claris, il primo fondo di venture capital italiano che investe solo nel biotech tricolore Ciro Spedaliere, Managing Partner of Claris Ventures, was interviewed by Business Insider, where he talked about Claris Biotech I, the first Italian VC fund focused on biotech that will be launched by Claris Ventures. Here the news Read more ↗ 
VentureUp Forum 2020 Ciro Spedaliere, Partner of Claris Ventures, will be in the panel “ Life Sciences: new frontiers and technologies ” of annual event VentureUp Forum by AIFI, the Italian association of private equity and venture capital. Read more ↗ 2019
Claris Ventures special guest at 39° Congresso Nazionale della Società Italiana di Farmacologia (SIF) The 39° National Congress of the Italian Pharmacology Society will be held in Florence from November 20th to 23rd. Claris Ventures will be a guest of the Symposium “ Innovation Flow and the players for translational research “. Read more ↗ 
Claris Ventures joins Torino City Lab Claris Ventures joins Torino City Lab , a initiative-platform aimed at creating simplified conditions for companies interested in conducting testing in real conditions of innovative solutions for urban living. Promoted by the City… Read more ↗ 
Kither Biotech raises a €5.6m financing round to support the clinical development of a new drug for cystic fibrosis and other pulmonary diseases Turin (Italy) – 5 July, 2019 – Kither Biotech, a spin-off company from the University of Turin focusing on the development of new treatments for pulmonary diseases, announces a Series A financing round of €5.6m. The company, based… Read more ↗ 
Claris Ventures guest speaker at “The drug from basic research to therapy” convention organized by the Italian Society of Pharmacology Pietro Puglisi, Managing Partner of Claris Ventures, will participate on 20/5 at the event “The drug from basic research to therapy” organized by Farmindustria, SIF – Italian Society of Pharmacology and University of Milan. Claris… Read more ↗ 
Pietro Puglisi from Claris Ventures interviewed by national TV Pietro Puglisi, Managing Partner of Claris Ventures, speaks at the RAI television program “ L’ITALIA CON VOI ” to talk about Italian innovation. Read more ↗ Start a conversation